Impact of nonalcoholic fatty liver disease on clinical outcomes in patients with COVID-19 among persons living with HIV: A multicenter research network study
Under a Creative Commons license
open access
Abbreviations
PLWH
Persons living with human immunodeficiency virus
HIV
human immunodeficiency virus
NAFLD
nonalcoholic fatty liver disease
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
COVID-19
Coronavirus disease 2019
HT
Hypertension
T2DM
type 2 diabetes mellitus
HF
heart failure
BMI
Body mass index
ALT
Alanine aminotransferase
ALP
Alkaline phosphatase
AST
Aspartate aminotransferase
BUN
Blood urea nitrogen
CI
Confidence interval
CRP
C-reactive protein
GGT
Gamma-glutamyl transpeptidase
RR
Risk ratios
PT
Prothrombin time
SD
Standard deviations
T-Bil
Total bilirubin
LDH
Lactate dehydrogenase
NNRTIs
non-nucleoside reverse transcriptase inhibitors
NRTIs
nucleoside reverse transcriptase inhibitors
CD
cluster of differentiation
RNA
ribonucleic acid
Keywords
SARS-CoV-2
COVID-19
HIV
Non-alcohol fatty liver disease
NAFLD
Outcomes
Mortality
Fatty liver disease
Syndemic
Health care
Cited by (0)
© 2023 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.